Australia
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
15.42%
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
2 |
13.00%
|
June 30, 2024 | USD 195.76 | 0.28% |
|
Australia |
|
3 |
9.42%
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
4 |
6.95%
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
5 |
4.84%
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
6 |
4.04%
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
7 |
3.45%
|
June 30, 2024 | USD 17.72 | 0.58% |
|
Australia |
|
8 |
1.31%
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
9 |
-1.28%
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
10 |
-8.16%
|
June 30, 2024 | USD 1.90 | 0.29% |
|
Australia |
|
11 |
-10.24%
|
Dec. 31, 2023 | USD 1.45 | -3.95% |
|
Australia |
|
12 |
-13.14%
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
13 |
-15.24%
|
June 30, 2024 | USD 2.89 | 2.85% |
|
Australia |
|
14 |
-21.19%
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
15 |
-21.65%
|
June 30, 2024 | USD 0.87 | -0.82% |
|
Australia |
|
16 |
-147.33%
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
The Biotechnology company in Australia with the highest Return on Assets (ROA) is Clinuvel Pharmaceuticals Limited (ASX: CUV.AX) at 15.42%.
The Biotechnology company in Australia with the lowest Return on Assets (ROA) is Anteris Technologies Ltd (ASX: AVR.AX) at -147.33%.
The top 10 Biotechnology companies in Australia by Return on Assets (ROA) are Clinuvel Pharmaceuticals Limited, Cochlear Limited, Cogstate Limited, CSL Limited, PolyNovo Limited, Australian Clinical Labs Limited, Sonic Healthcare Limited, Telix Pharmaceuticals Limited, Monash IVF Group Limited and Integral Diagnostics Limited.
The bottom 10 Biotechnology companies in Australia by Return on Assets (ROA) are Anteris Technologies Ltd, Healius Limited, Immutep Limited, Mayne Pharma Group Limited, Mesoblast Limited, Cyclopharm Limited, Integral Diagnostics Limited, Monash IVF Group Limited, Telix Pharmaceuticals Limited and Sonic Healthcare Limited.